Samuel C. Blackman Sells 10,000 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Stock

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) insider Samuel C. Blackman sold 10,000 shares of Day One Biopharmaceuticals stock in a transaction dated Thursday, April 18th. The shares were sold at an average price of $16.02, for a total value of $160,200.00. Following the completion of the sale, the insider now owns 1,174,662 […]

Related Keywords

Wellington ,New Zealand General ,New Zealand ,Piper Sandler ,Samuelc Blackman ,Fisher Asset Management ,Goldman Sachs Group ,Jpmorgan Chase Co ,Day One Biopharmaceuticals Inc ,Goldman Sachs Group Inc ,Nasdaq ,Day One Biopharmaceuticals Company Profile ,Hennion Walsh Asset Management Inc ,Wellington Management Group ,Securities Exchange Commission ,Quintet Private Bank Europe ,Day One Biopharmaceuticals ,Get Free Report ,Exchange Commission ,One Biopharmaceuticals ,Walsh Asset Management ,Asset Management ,Management Group ,Sachs Group ,Day One Biopharmaceuticals Daily ,Nasdaq Dawn ,Dawn ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,